Latest Insider Transactions at Corvus Pharmaceuticals, Inc. (CRVS)
This section provides a real-time view of insider transactions for Corvus Pharmaceuticals, Inc. (CRVS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Corvus Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Corvus Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 10
2024
|
Richard A Md Miller President and CEO |
SELL
Bona fide gift
|
Indirect |
302,016
-20.27%
|
-
|
|
May 06
2024
|
Richard A Md Miller President and CEO |
BUY
Open market or private purchase
|
Direct |
577,634
+50.0%
|
$577,634
$1.73 P/Share
|
|
May 06
2024
|
William Benton Jones |
BUY
Open market or private purchase
|
Direct |
20,000
+11.51%
|
$20,000
$1.73 P/Share
|
|
May 15
2023
|
Linda Grais |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$20,000
$2.45 P/Share
|
|
Dec 20
2022
|
William Benton Jones |
BUY
Open market or private purchase
|
Direct |
20,000
+13.01%
|
$0
$0.79 P/Share
|
|
Dec 14
2022
|
Leiv Lea Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
4,000
+2.91%
|
$0
$0.84 P/Share
|
|
Dec 14
2022
|
Richard A Md Miller President and CEO |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.67%
|
$0
$0.78 P/Share
|
|
Dec 13
2022
|
Leiv Lea Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
30,000
+18.84%
|
$0
$0.74 P/Share
|
|
Dec 13
2022
|
Richard A Md Miller President and CEO |
BUY
Open market or private purchase
|
Indirect |
50,000
+3.27%
|
$0
$0.74 P/Share
|
|
Sep 28
2022
|
Richard A Md Miller President and CEO |
BUY
Open market or private purchase
|
Indirect |
25,000
+1.76%
|
$0
$0.76 P/Share
|
|
Sep 20
2022
|
Richard A Md Miller President and CEO |
BUY
Open market or private purchase
|
Indirect |
20,000
+0.49%
|
$0
$0.82 P/Share
|
|
Jun 27
2022
|
Richard A Md Miller President and CEO |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.37%
|
$5,000
$1.0 P/Share
|
|
Jun 24
2022
|
Richard A Md Miller President and CEO |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.37%
|
$5,000
$1.03 P/Share
|
|
Jun 06
2022
|
Richard A Md Miller President and CEO |
BUY
Open market or private purchase
|
Indirect |
890
+0.07%
|
$890
$1.01 P/Share
|
|
Jun 02
2022
|
Richard A Md Miller President and CEO |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.19%
|
$0
$0.98 P/Share
|
|
Mar 31
2022
|
Richard A Md Miller President and CEO |
BUY
Open market or private purchase
|
Indirect |
15,000
+1.11%
|
$15,000
$1.64 P/Share
|
|
Mar 17
2022
|
Leiv Lea Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
13,878
+12.27%
|
$13,878
$1.65 P/Share
|
|
Mar 17
2022
|
Richard A Md Miller President and CEO |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.38%
|
$5,000
$1.59 P/Share
|
|
Mar 16
2022
|
Leiv Lea Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
35,160
+29.17%
|
$35,160
$1.54 P/Share
|
|
Mar 15
2022
|
Richard A Md Miller President and CEO |
BUY
Open market or private purchase
|
Indirect |
25,000
+1.87%
|
$25,000
$1.47 P/Share
|
|
Oct 01
2021
|
Eco R1 Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,000,000
-96.1%
|
$8,000,000
$4.96 P/Share
|
|
Sep 30
2021
|
Eco R1 Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
3,000,000
-59.04%
|
$15,000,000
$5.04 P/Share
|
|
Sep 20
2021
|
Peter A. Thompson |
SELL
Open market or private sale
|
Indirect |
1,109,644
-13.78%
|
$6,657,864
$6.09 P/Share
|
|
Sep 20
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
1,109,644
-13.78%
|
$6,657,864
$6.09 P/Share
|
|
Aug 20
2021
|
Richard A Md Miller President and CEO |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.77%
|
$10,000
$1.93 P/Share
|
|
May 04
2021
|
Richard A Md Miller President and CEO |
BUY
Open market or private purchase
|
Direct |
35,714
+50.0%
|
$71,428
$2.8 P/Share
|
|
Feb 17
2021
|
Peter A. Thompson |
BUY
Open market or private purchase
|
Indirect |
1,285,714
+13.77%
|
$3,857,142
$3.5 P/Share
|
|
Feb 17
2021
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
1,285,714
+13.77%
|
$3,857,142
$3.5 P/Share
|
|
Feb 17
2021
|
Richard A Md Miller President and CEO |
BUY
Open market or private purchase
|
Indirect |
100,000
+7.25%
|
$300,000
$3.5 P/Share
|
|
Jul 08
2020
|
Novo Holdings > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
741,440
-34.79%
|
$3,707,200
$5.37 P/Share
|
|
Jul 07
2020
|
Novo Holdings > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
796,622
-27.21%
|
$3,983,110
$5.25 P/Share
|
|
Aug 06
2019
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
142,656
+2.06%
|
$427,968
$3.51 P/Share
|
|
Jul 25
2019
|
Novo Holdings > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,400,000
-32.35%
|
$5,600,000
$4.0 P/Share
|
|
Jul 24
2019
|
Novo Holdings > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
53,240
-1.22%
|
$266,200
$5.01 P/Share
|
|
Jul 23
2019
|
Novo Holdings > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
39,716
-0.9%
|
$198,580
$5.32 P/Share
|
|
Jul 01
2019
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
59,243
+0.89%
|
$177,729
$3.91 P/Share
|
|
Jun 28
2019
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
565,178
+7.93%
|
$1,695,534
$3.72 P/Share
|
|
Jun 27
2019
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
32,923
+0.55%
|
$98,769
$3.34 P/Share
|
|
Mar 12
2018
|
Adams Street Partners LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
588,235
+50.0%
|
$4,705,880
$8.5 P/Share
|
|
Mar 12
2018
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
588,235
+8.97%
|
$4,705,880
$8.5 P/Share
|
|
Mar 12
2018
|
Novo Holdings > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,176,470
+21.02%
|
$9,411,760
$8.5 P/Share
|